Preclinical stress research: where are we headed? An early career 
investigator's perspective

Gururajan, Anand; Kos, Aron; Lopez, Juan Pablo

doi:10.1080/10253890.2018.1446519

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsStatisticsRelease HistoryDetailsSummary

Released

Journal Article

Preclinical stress research: where are we headed? An early career investigator's perspective

MPS-Authors

/persons/resource/persons227188

Kos, Aron
Dept. Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons222540

Lopez, Juan Pablo
Dept. Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Max Planck Society;

External Ressource

No external resources are shared

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gururajan, A., Kos, A., & Lopez, J. P. (2018). Preclinical stress research: where are we headed? An early career investigator's perspective. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 21(5), 384-388. doi:10.1080/10253890.2018.1446519.

Cite as: http://hdl.handle.net/21.11116/0000-0003-674C-5

Abstract

Stress is a major risk factor in the development of various psychiatric disorders such as depression, anxiety and post-traumatic stress disorder. The use of stress paradigms in preclinical contexts is essential to advance our understanding of the pathophysiology of these disorders. However, they are not without their limitations and in this commentary, we have examined some of the practical issues associated with their use. We also highlight some of the latest techniques to identify their neuromolecular correlates as well as the potentially important and integrative role of computational neuroscience. Finally, we share our perspective on future directions in the field of preclinical stress research.